Organigram Global Inc Quick Ratio (OGI) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Organigram Global Inc   (NASDAQ: OGI)

Organigram Global Inc 's Quick Ratio

OGI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2025, Quick Ratio deteriorated to 0.22 a new company low.

Within Major Pharmaceutical Preparations industry 422 other companies have achieved higher Quick Ratio than Organigram Global Inc in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from to 2983.

Explain Quick Ratio?
How much Cash & cash equivalents OGI´s has?
What are OGI´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OGI Quick Ratio (Sep 30 2025)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Sep 30 2024)
Q4
Y / Y Current Liabilities Change 136.6 % 136.6 % 136.6 % 136.6 % 137.72 %
Y / Y Cash & cash equivalent Change -73.58 % -73.58 % -73.58 % -73.58 % 215.22 %
Quick Ratio MRQ 0.22 0.22 0.22 0.22 2
OGI's Total Ranking # 2983 # # # #
Seq. Current Liabilities Change 0 % 0 % 0 % 136.6 % 0 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -73.58 % 0 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 423
Healthcare Sector # 819
Overall Market # 2983


Quick Ratio Statistics
High Average Low
2 1.25 0.22
(Sep 30 2024)   (Sep 30 2025)




Financial Statements
Organigram Global Inc 's Current Liabilities $ 97 Millions Visit OGI's Balance sheet
Organigram Global Inc 's Cash & cash equivalent $ 22 Millions Visit OGI's Balance sheet
Source of OGI's Sales Visit OGI's Sales by Geography


Cumulative Organigram Global Inc 's Quick Ratio

OGI's Quick Ratio for the trailling 12 Months

OGI Quick Ratio

 (Sep 30 2025)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Sep 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth 136.6 % 136.74 % 136.93 % 137.22 % 137.72 %
Y / Y Cash & cash equivalent TTM Growth -73.58 % -45.96 % -4.03 % 67.25 % 215.22 %
Quick Ratio TTM 0.22 0.44 0.75 1.22 2
Total Ranking TTM # 4192 # # # #
Seq. Current Liabilities TTM Growth 16.87 % 20.29 % 25.46 % 34.15 % 16.94 %
Seq. Cash & cash equivalent TTM Growth -41.05 % -29.1 % -22.54 % -18.4 % 20.58 %

Quick ratio ranking by company, industry and sector >> Back to OGI Financial Strength Comparisons >> Go to Compare OGI Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q4 2025 to $96.64 millions, cumulative Quick Ratio decreased to 0.22 below the Organigram Global Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 500 other companies have achieved higher Quick Ratio than Organigram Global Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from to 4192.

Explain Quick Ratio?
How much Cash & cash equivalents OGI´s has?
What are OGI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 501
Healthcare Sector # 1010
Within the Market # 4192


trailing twelve months Quick Ratio Statistics
High Average Low
2 1.02 0.22
(Sep 30 2024)   (Sep 30 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2025 MRQ Cash & cash equivalentSep 30 2025 MRQ Current Liabilities
Bristol myers Squibb Company  0.59 $ 16,502.000  Millions$ 28,136.000  Millions
Aurinia Pharmaceuticals Inc   0.58 $ 72.889  Millions$ 124.931  Millions
Jazz Pharmaceuticals Plc  0.58 $ 1,326.070  Millions$ 2,274.102  Millions
Ironwood Pharmaceuticals inc   0.58 $ 140.407  Millions$ 242.503  Millions
Ascendis Pharma A  0.58 $ 691.961  Millions$ 1,197.718  Millions
Galapagos Nv  0.57 $ 98.412  Millions$ 171.207  Millions
Phibro Animal Health Corporation  0.57 $ 85.273  Millions$ 149.041  Millions
Assertio Holdings inc   0.56 $ 93.427  Millions$ 166.783  Millions
Karyopharm Therapeutics Inc   0.53 $ 45.877  Millions$ 87.157  Millions
Nls Pharmaceutics Ltd  0.52 $ 2.201  Millions$ 4.195  Millions
Apollomics Inc   0.52 $ 3.276  Millions$ 6.326  Millions
Aytu Biopharma Inc  0.49 $ 32.630  Millions$ 65.993  Millions
Elanco Animal Health Incorporated  0.47 $ 505.000  Millions$ 1,079.000  Millions
Omeros Corporation  0.45 $ 36.085  Millions$ 80.756  Millions
Eli Lilly And Company  0.44 $ 9,913.500  Millions$ 22,520.700  Millions
Genprex Inc   0.43 $ 1.103  Millions$ 2.552  Millions
Novartis Ag  0.43 $ 11,640.000  Millions$ 27,278.000  Millions
Indivior Pharmaceuticals Inc   0.42 $ 445.000  Millions$ 1,048.000  Millions
Perrigo Company Plc  0.42 $ 432.100  Millions$ 1,035.400  Millions
Grifols Sa  0.42 $ 943.040  Millions$ 2,261.280  Millions
Cormedix Inc   0.42 $ 55.717  Millions$ 133.644  Millions
Pfizer Inc  0.41 $ 14,984.000  Millions$ 36,596.000  Millions
Lftd Partners Inc   0.41 $ 1.971  Millions$ 4.827  Millions
Carisma Therapeutics Inc   0.41 $ 2.777  Millions$ 6.812  Millions
Telix Pharmaceuticals Ltd  0.38 $ 147.909  Millions$ 392.476  Millions
Earth Science Tech Inc   0.37 $ 1.268  Millions$ 3.392  Millions
Applied Therapeutics Inc   0.36 $ 11.945  Millions$ 32.902  Millions
Tiziana Life Sciences Ltd  0.36 $ 4.010  Millions$ 11.209  Millions
Genmab A  0.34 $ 1,715.000  Millions$ 5,001.000  Millions
Medicure Inc   0.33 $ 2.938  Millions$ 8.896  Millions

Date modified: 2026-06-22T16:58:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.